Common-Size Balance Sheet: Assets
Paying user area
Try for free
Cytokinetics Inc. pages available for free this week:
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Operating Profit Margin since 2005
- Current Ratio since 2005
- Debt to Equity since 2005
- Price to Book Value (P/BV) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Cytokinetics Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Cytokinetics Inc., common-size consolidated balance sheet: assets
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
- Cash and Cash Equivalents
- The percentage of cash and cash equivalents relative to total assets decreased consistently over the period, starting at 20.01% in 2018 and declining to 6.46% in 2022. This indicates a diminishing liquidity position in terms of immediately available cash resources.
- Short-term Investments
- Short-term investments remained the largest component of total assets, with some fluctuation. They started at 74.1% in 2018, dipped notably to 42.67% in 2021, before rising again to 70.66% in 2022. This suggests periodic reallocation or realizations affecting short-term investment holdings.
- Accounts Receivable
- Accounts receivable showed variability with no clear trend; from a low 1.06% in 2018, it increased to 6.16% in 2021, then sharply declined to nearly negligible at 0.01% in 2022. This could indicate changes in credit policies, sales timing, or collection effectiveness.
- Contract Assets
- Contract assets were reported only in 2018 at 2.16%, with no data available in subsequent years, suggesting either reclassification or absence of contract assets in later periods.
- Prepaid Expenses and Other Current Assets
- This category remained relatively stable, fluctuating slightly between 1.02% and 1.45% across the years, indicating minimal changes in prepaid or other miscellaneous current asset levels.
- Current Assets
- The proportion of current assets to total assets demonstrated a declining trend after a peak of 98.34% in 2018, falling to a low of 63.67% in 2021 before recovering modestly to 78.36% in 2022. This reflects a shift towards greater asset diversification or increased investment in non-current items.
- Long-term Investments
- Long-term investments were absent in 2018 but appeared at 14.72% in 2019, then declined to 4.6% by 2022 after some fluctuation. This pattern suggests strategic adjustments in longer-term asset holdings.
- Property and Equipment, Net
- There was a noticeable increase in property and equipment assets from 1.52% in 2018 to a peak of 8.71% in 2021, followed by a slight decrease to 7.93% in 2022, indicating investments in fixed assets over time.
- Operating Lease Right-of-Use Assets
- First reported in 2020 at 0.55%, this category expanded significantly to over 8% in 2021 and 2022, reflecting adoption of lease accounting standards and increased recognition of lease assets on the balance sheet.
- Other Assets
- Other assets fluctuated with a peak of 3.06% in 2019 but remained under 1% in other years, indicating minor overall impact on asset composition.
- Non-current Assets
- The share of non-current assets grew significantly from 1.66% in 2018 to a high of 36.33% in 2021 before declining to 21.64% in 2022, evidencing increased investment in long-term assets, including property, equipment, lease assets, and long-term investments, particularly in the years 2019-2021.
- Total Assets
- As expected, the total of all asset components remained constant at 100% across all years, confirming the relative perspective of the data.